首页 > 最新文献

Photodermatology, photoimmunology & photomedicine最新文献

英文 中文
The effects of infrared radiation on the human skin. 红外线辐射对人体皮肤的影响。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-11-01 Epub Date: 2023-07-11 DOI: 10.1111/phpp.12899
Luke Horton, Joshua Brady, Colin M Kincaid, Angeli Eloise Torres, Henry W Lim

Background: Infrared radiation (IR) is the portion of the electromagnetic spectrum between visible light (VL) and microwaves, with wavelengths between 700 nm and 1 mm. Humans are mainly exposed to ultraviolet (UV) radiation (UVR) and IR through the sun. Unlike UVR which is well known for its carcinogenic properties, the relationship between IR and skin health has not been as extensively studied; as such, we gather the available published evidence here to better elucidate this relationship.

Methods: Several databases including Pubmed, Google Scholar, and Embase were searched for articles relating to infrared radiation and the skin. Articles were selected for their relevance and novelty.

Results: Detrimental effects such as thermal burns, photocarcinogenesis, and photoaging have been reported, though evidence suggests that these may be due to the thermal effects produced secondary to IR exposure rather than the isolated effect of IR. There are currently no chemical or physical filters specifically available for protection against IR, and existing compounds are not known to have IR-filtering capacity. Interestingly, IR may have some photoprotective properties against the carcinogenic effects of UVR. Furthermore, IR has been used with encouraging results in skin rejuvenation, wound healing, and hair restoration when given at an appropriate therapeutic dose.

Conclusion: A better understanding of the current landscape of research surrounding IR can help illuminate its effects on the skin and highlight areas for further research. Here, we review relevant data on IR to assess its deleterious and beneficial effects on human skin, along with possible means for IR photoprotection.

背景:红外辐射(IR)是介于可见光(VL)和微波之间的电磁波谱部分,波长在700 nm到1 mm之间。人类主要通过太阳暴露在紫外线(UV)辐射(UVR)和红外辐射(IR)下。与众所周知的紫外线辐射致癌特性不同,紫外线辐射与皮肤健康之间的关系尚未得到广泛研究;因此,我们在这里收集了现有的已发表的证据,以更好地阐明这种关系。方法:检索Pubmed、谷歌Scholar、Embase等数据库中与红外辐射与皮肤相关的文献。文章是根据相关性和新颖性选出的。结果:热烧伤、光致癌和光老化等有害影响已被报道,尽管有证据表明,这些可能是由于红外暴露后产生的热效应,而不是红外的孤立效应。目前还没有化学或物理过滤器专门用于防止红外,现有的化合物也不知道具有红外过滤能力。有趣的是,红外线可能对紫外线的致癌作用有一定的光保护作用。此外,当给予适当的治疗剂量时,IR已在皮肤年轻化,伤口愈合和头发恢复方面取得了令人鼓舞的结果。结论:更好地了解红外辐射的研究现状有助于阐明其对皮肤的影响,并突出进一步研究的领域。在这里,我们回顾了有关红外的相关数据,以评估其对人体皮肤的有害和有益影响,以及可能的红外光防护方法。
{"title":"The effects of infrared radiation on the human skin.","authors":"Luke Horton, Joshua Brady, Colin M Kincaid, Angeli Eloise Torres, Henry W Lim","doi":"10.1111/phpp.12899","DOIUrl":"10.1111/phpp.12899","url":null,"abstract":"<p><strong>Background: </strong>Infrared radiation (IR) is the portion of the electromagnetic spectrum between visible light (VL) and microwaves, with wavelengths between 700 nm and 1 mm. Humans are mainly exposed to ultraviolet (UV) radiation (UVR) and IR through the sun. Unlike UVR which is well known for its carcinogenic properties, the relationship between IR and skin health has not been as extensively studied; as such, we gather the available published evidence here to better elucidate this relationship.</p><p><strong>Methods: </strong>Several databases including Pubmed, Google Scholar, and Embase were searched for articles relating to infrared radiation and the skin. Articles were selected for their relevance and novelty.</p><p><strong>Results: </strong>Detrimental effects such as thermal burns, photocarcinogenesis, and photoaging have been reported, though evidence suggests that these may be due to the thermal effects produced secondary to IR exposure rather than the isolated effect of IR. There are currently no chemical or physical filters specifically available for protection against IR, and existing compounds are not known to have IR-filtering capacity. Interestingly, IR may have some photoprotective properties against the carcinogenic effects of UVR. Furthermore, IR has been used with encouraging results in skin rejuvenation, wound healing, and hair restoration when given at an appropriate therapeutic dose.</p><p><strong>Conclusion: </strong>A better understanding of the current landscape of research surrounding IR can help illuminate its effects on the skin and highlight areas for further research. Here, we review relevant data on IR to assess its deleterious and beneficial effects on human skin, along with possible means for IR photoprotection.</p>","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9764396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultraviolet B-induced punctate hyperkeratosis in a patient with vitiligo. 紫外线B诱导的点状角化过度症在白癜风患者中的应用。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-08 DOI: 10.1111/phpp.12916
Chang-Yu Hsieh, Tsen-Fang Tsai
{"title":"Ultraviolet B-induced punctate hyperkeratosis in a patient with vitiligo.","authors":"Chang-Yu Hsieh, Tsen-Fang Tsai","doi":"10.1111/phpp.12916","DOIUrl":"10.1111/phpp.12916","url":null,"abstract":"","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41168879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CO2 laser combined with ALA-PDT for successful treatment of refractory acne vulgaris: A case report. CO2激光联合ALA-PDT治疗难治性寻常痤疮1例。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-09-01 Epub Date: 2023-04-19 DOI: 10.1111/phpp.12875
Qin Chen, Ling Li, Zhi-Qiang Song, Lan Ge
Dear editors, Acne vulgaris is a common skin disease of showing alteration of the keratinization process causing the progression from comedone formation to inflammatory response.1 Generally, acne vulgaris clinically responds well to the treatments such as salicylic acid, antibiotics, and/or combination with isotretinoin. However, in some individuals, acne vulgaris does not response to topical treatments or oral pharmacological interventions.2 Thus, these individuals with treatmentresistant acne vulgaris, socalled refractory acne vulgaris (RAV), require alternative options for the effective treatment. A 22yearold male patient presented to our dermatology outpatient unit with a 4year history of bilaterally facial acne vulgaris. Clinical examination showed a large number of comedones fused into one piece with inflammatory lesions on his faces (Figure 1A). The patient reported no respond to the treatment with oral isotretinoin (0.5 mg/kg/day). Therefore, the combinations of oral isotretinoin (0.5 mg/kg/day) and topical 30% salicylic acid (six times, one time per 2– 3 weeks) or alpha hydroxyl acid with adapalene gel as well as clindamycin hydrochloride and metronidazole liniments were initially used to treat the patient. After 3 months, the numbers of inflammatory lesions were slightly decreased. However, the patient reported a recurrence of superficial acne, and no alteration of the deep acne was observed (Figure 1B). Given an unsuccessful treatment with mediations, CO2 laser therapy was subsequently selected as an alternative treatment following the patient stopped taking medications for 2 weeks. The patient was treated with an ablative 10,600 nm fractional CO2 laser systems (Chongqing Jingyu Laser Technology Co., Ltd). Meanwhile, needle acupuncture was used to extrude fat plugs following CO2 laser therapy. After 2 months, the large facial acne still existed, though part of the comedones disappeared, and decreased numbers of inflammatory lesions were also observed (Figure 1C). Due to previous unsatisfactory curative effect, CO2 laser combined with 5aminolaevulinic acid photodynamic therapy (ALAPDT) were further performed. The treatment process showed as follows: CO2 laser described as above was used to vaporize the tip of comedones to form small pores, and the fat plugs were extruded by using needle acupuncture. Topical 5% ALA was immediately applied, and sterile cottons soaked with 5% ALA were covered bilaterally facial surface for 2 h. Then, Light irradiation was carried out by exposing the bilaterally facial surface to a red LED device (640 nm, Shenzhen Pumen Technology Co., Ltd) at the dose level of 72 mw/cm2 for 20 min, followed by cooling with ice for 2 h. The treatment was performed every 2 weeks. After 3 times of treatment, the facial acne was significantly improved with few inflammatory lesions and some scattered erythema and sunken acne pits (Figure 1D). The halfyear followup medical examinations showed only some sunken acne pits and no re
{"title":"CO<sub>2</sub> laser combined with ALA-PDT for successful treatment of refractory acne vulgaris: A case report.","authors":"Qin Chen,&nbsp;Ling Li,&nbsp;Zhi-Qiang Song,&nbsp;Lan Ge","doi":"10.1111/phpp.12875","DOIUrl":"10.1111/phpp.12875","url":null,"abstract":"Dear editors, Acne vulgaris is a common skin disease of showing alteration of the keratinization process causing the progression from comedone formation to inflammatory response.1 Generally, acne vulgaris clinically responds well to the treatments such as salicylic acid, antibiotics, and/or combination with isotretinoin. However, in some individuals, acne vulgaris does not response to topical treatments or oral pharmacological interventions.2 Thus, these individuals with treatmentresistant acne vulgaris, socalled refractory acne vulgaris (RAV), require alternative options for the effective treatment. A 22yearold male patient presented to our dermatology outpatient unit with a 4year history of bilaterally facial acne vulgaris. Clinical examination showed a large number of comedones fused into one piece with inflammatory lesions on his faces (Figure 1A). The patient reported no respond to the treatment with oral isotretinoin (0.5 mg/kg/day). Therefore, the combinations of oral isotretinoin (0.5 mg/kg/day) and topical 30% salicylic acid (six times, one time per 2– 3 weeks) or alpha hydroxyl acid with adapalene gel as well as clindamycin hydrochloride and metronidazole liniments were initially used to treat the patient. After 3 months, the numbers of inflammatory lesions were slightly decreased. However, the patient reported a recurrence of superficial acne, and no alteration of the deep acne was observed (Figure 1B). Given an unsuccessful treatment with mediations, CO2 laser therapy was subsequently selected as an alternative treatment following the patient stopped taking medications for 2 weeks. The patient was treated with an ablative 10,600 nm fractional CO2 laser systems (Chongqing Jingyu Laser Technology Co., Ltd). Meanwhile, needle acupuncture was used to extrude fat plugs following CO2 laser therapy. After 2 months, the large facial acne still existed, though part of the comedones disappeared, and decreased numbers of inflammatory lesions were also observed (Figure 1C). Due to previous unsatisfactory curative effect, CO2 laser combined with 5aminolaevulinic acid photodynamic therapy (ALAPDT) were further performed. The treatment process showed as follows: CO2 laser described as above was used to vaporize the tip of comedones to form small pores, and the fat plugs were extruded by using needle acupuncture. Topical 5% ALA was immediately applied, and sterile cottons soaked with 5% ALA were covered bilaterally facial surface for 2 h. Then, Light irradiation was carried out by exposing the bilaterally facial surface to a red LED device (640 nm, Shenzhen Pumen Technology Co., Ltd) at the dose level of 72 mw/cm2 for 20 min, followed by cooling with ice for 2 h. The treatment was performed every 2 weeks. After 3 times of treatment, the facial acne was significantly improved with few inflammatory lesions and some scattered erythema and sunken acne pits (Figure 1D). The halfyear followup medical examinations showed only some sunken acne pits and no re","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10271266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of related factors affecting hemoporfin-mediated photodynamic therapy for port-wine stain: A retrospective study. 影响血红蛋白介导的葡萄酒色斑光动力治疗的相关因素分析:一项回顾性研究。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1111/phpp.12874
Jiajie Chen, Yu Gui, Sun Wang, Dawei Huang, Jiajie Lyu, Hui Cheng, Yantao Ding, Huabing Zhang, Shengxiu Liu

Background: Hemoporfin-mediated photodynamic therapy (HMME-PDT) is currently considered one of the most promising therapies for port-wine stain (PWS). However, the efficacy of this is very variable and needs further studies.

Methods: A total of 101 patients with PWS in the face, neck, or extremities who received at least 2 HMME-PDT sessions were included in the study, and correlations of efficacy with age, gender, locations, treatment sessions, and PDL treatment history were analyzed.

Results: The efficacy of HMME-PDT in patients with different ages, locations, and different numbers of prior PDL treatment showed constantly significant differences after 1/2/last session (p < .05). The number of treatments was associated with efficacy, and patients who received more than two sessions had a better response than those who underwent two sessions only (p < .001). Ordinal logistic regression analysis confirmed the above-mentioned associations. Nevertheless, patients of different sex, subtype, and lesion size showed no significant differences.

Conclusions: Our studies demonstrated that HMME-PDT is effective in the treatment of PWS. The more prior PDL treatments, older age, lips involvement, PWS on limbs were adverse factors for Hemoporfin-PDT, while multiple HMME-PDT sessions can improve effective and response rate. Besides, ambient temperature and lesions temperature should be concerned, local cooling provides some relief from pain but may influence effect.

背景:hemoporin介导的光动力疗法(HMME-PDT)被认为是目前最有前途的治疗port-wine stain (PWS)的方法之一。然而,这种方法的效果变化很大,需要进一步研究。方法:本研究共纳入101例面部、颈部或四肢PWS患者,患者接受了至少2次HMME-PDT治疗,分析其疗效与年龄、性别、部位、治疗时间和PDL治疗史的相关性。结果:HMME-PDT在不同年龄、部位、不同既往PDL治疗次数的患者中,疗效在1/2/ 1次后持续存在显著差异(p)。结论:我们的研究表明,HMME-PDT治疗PWS有效。既往PDL治疗次数多、年龄大、唇部受累、肢体PWS是Hemoporfin-PDT的不利因素,而多次HMME-PDT治疗可提高疗效和缓解率。此外,应注意环境温度和病灶温度,局部降温可缓解疼痛,但可能影响效果。
{"title":"Analysis of related factors affecting hemoporfin-mediated photodynamic therapy for port-wine stain: A retrospective study.","authors":"Jiajie Chen,&nbsp;Yu Gui,&nbsp;Sun Wang,&nbsp;Dawei Huang,&nbsp;Jiajie Lyu,&nbsp;Hui Cheng,&nbsp;Yantao Ding,&nbsp;Huabing Zhang,&nbsp;Shengxiu Liu","doi":"10.1111/phpp.12874","DOIUrl":"https://doi.org/10.1111/phpp.12874","url":null,"abstract":"<p><strong>Background: </strong>Hemoporfin-mediated photodynamic therapy (HMME-PDT) is currently considered one of the most promising therapies for port-wine stain (PWS). However, the efficacy of this is very variable and needs further studies.</p><p><strong>Methods: </strong>A total of 101 patients with PWS in the face, neck, or extremities who received at least 2 HMME-PDT sessions were included in the study, and correlations of efficacy with age, gender, locations, treatment sessions, and PDL treatment history were analyzed.</p><p><strong>Results: </strong>The efficacy of HMME-PDT in patients with different ages, locations, and different numbers of prior PDL treatment showed constantly significant differences after 1/2/last session (p < .05). The number of treatments was associated with efficacy, and patients who received more than two sessions had a better response than those who underwent two sessions only (p < .001). Ordinal logistic regression analysis confirmed the above-mentioned associations. Nevertheless, patients of different sex, subtype, and lesion size showed no significant differences.</p><p><strong>Conclusions: </strong>Our studies demonstrated that HMME-PDT is effective in the treatment of PWS. The more prior PDL treatments, older age, lips involvement, PWS on limbs were adverse factors for Hemoporfin-PDT, while multiple HMME-PDT sessions can improve effective and response rate. Besides, ambient temperature and lesions temperature should be concerned, local cooling provides some relief from pain but may influence effect.</p>","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10331066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Response predictor for pigment reduction after one session of photo-based therapy using convolutional neural network: A proof of concept study. 使用卷积神经网络进行一次光疗后色素减少的反应预测:概念研究的证明。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1111/phpp.12891
Ting-Ting Yang, Ching-Wen Ma, Jyun-Wei Jhou, Yu-Ting Chen, Cheng-Che E Lan

Background: Identifying treatment responders after a single session of photo-based procedure for hyperpigmentary disorders may be difficult.

Objectives: We aim to train a convolutional neural network (CNN) to test the hypothesis that there exist discernible features in pretreatment photographs for identifying favorable responses after photo-based treatments for facial hyperpigmentation and develop a clinically applicable algorithm to predict treatment outcome.

Methods: Two hundred and sixty-four sets of pretreatment photographs of subjects receiving photo-based treatment for esthetic enhancement were obtained using the VISIA® skin analysis system. Preprocessing was done by masking the facial features of the photographs. Each set of photographs consists of five types of images. Five independently trained CNNs based on the Resnet50 backbone were developed based on these images and the results of these CNNs were combined to obtain the final result.

Results: The developed CNN algorithm has a prediction accuracy approaching 78.5% with area under the receiver operating characteristic curve being 0.839.

Conclusion: The treatment efficacy of photo-based therapies on facial skin pigmentation can be predicted based on pretreatment images.

背景:在单次基于光的治疗过程中识别治疗反应可能是困难的。目的:我们旨在训练卷积神经网络(CNN)来验证预处理照片中存在可识别特征的假设,以识别基于照片的面部色素沉着过度治疗后的有利反应,并开发一种临床适用的算法来预测治疗结果。方法:使用VISIA®皮肤分析系统获得264组接受光敏美容治疗的受试者的预处理照片。通过掩盖照片的面部特征来进行预处理。每组照片由五种类型的图像组成。基于这些图像开发了基于Resnet50骨干网的5个独立训练的cnn,并将这些cnn的结果进行组合得到最终结果。结果:所开发的CNN算法预测准确率接近78.5%,受者工作特征曲线下面积为0.839。结论:光疗法对面部皮肤色素沉着的治疗效果可根据预处理图像进行预测。
{"title":"Response predictor for pigment reduction after one session of photo-based therapy using convolutional neural network: A proof of concept study.","authors":"Ting-Ting Yang,&nbsp;Ching-Wen Ma,&nbsp;Jyun-Wei Jhou,&nbsp;Yu-Ting Chen,&nbsp;Cheng-Che E Lan","doi":"10.1111/phpp.12891","DOIUrl":"https://doi.org/10.1111/phpp.12891","url":null,"abstract":"<p><strong>Background: </strong>Identifying treatment responders after a single session of photo-based procedure for hyperpigmentary disorders may be difficult.</p><p><strong>Objectives: </strong>We aim to train a convolutional neural network (CNN) to test the hypothesis that there exist discernible features in pretreatment photographs for identifying favorable responses after photo-based treatments for facial hyperpigmentation and develop a clinically applicable algorithm to predict treatment outcome.</p><p><strong>Methods: </strong>Two hundred and sixty-four sets of pretreatment photographs of subjects receiving photo-based treatment for esthetic enhancement were obtained using the VISIA® skin analysis system. Preprocessing was done by masking the facial features of the photographs. Each set of photographs consists of five types of images. Five independently trained CNNs based on the Resnet50 backbone were developed based on these images and the results of these CNNs were combined to obtain the final result.</p><p><strong>Results: </strong>The developed CNN algorithm has a prediction accuracy approaching 78.5% with area under the receiver operating characteristic curve being 0.839.</p><p><strong>Conclusion: </strong>The treatment efficacy of photo-based therapies on facial skin pigmentation can be predicted based on pretreatment images.</p>","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10331645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of pediatric indolent systemic mastocytosis: The role of UVB-NB phototherapy in the treatment of cutaneous lesions. 儿童无痛性系统性肥大细胞增多症一例:UVB-NB光疗在皮肤病变治疗中的作用。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-09-01 Epub Date: 2023-06-16 DOI: 10.1111/phpp.12894
Valeria Brazzelli, Grazia Bossi, Alice Bonelli, Eugenio Isoletta, Martina Volontè, Stefania Barruscotti, Mara De Amici, Elisa Bono, Jacqueline Ferrari, Emanuela Boveri
Dear editor, Mastocytosis encompasses a heterogeneous group of disorders characterized by pathological expansion and accumulation of clonal mast cells within one or more organs.1 According to the latest classification, three subtypes of the disease have been recognized based on the site and extent of organ involvement and dysfunction: cutaneous mastocytosis (CM), systemic mastocytosis (SM), and mast cell sarcoma (MCS).2,3 SM has been differentiated into nonadvanced and advanced forms, while the CM is divided into maculopapular CM (MPCM), diffuse CM (DCM), and mastocytoma subtypes.2,3 In pediatric age, mastocytosis is often limited to the skin (CM) and is considered to be a myeloproliferative clonal disease with benign course, outcome, and tendency to spontaneous resolution before puberty.4 Extracutaneous involvement in pediatric mastocytosis is relatively rare, most often presenting in the form of indolent systemic mastocytosis (ISM). Virtually all children with SM present with skin lesions, usually MPCM, accompanied by increased serum tryptase levels.4 Currently, the treatment of SM in pediatric patients lacks of standard guidelines: its primary aim is to limit the release of mediators of mast cell degranulation, by avoiding potential triggering factors. The mainstay of systemic therapy is secondgeneration H1 and H2 antihistamines, useful in decreasing flushing, pruritus, and controlling wheal formation.1,5 A valuable secondline therapy, proposed as an alternative approach for the treatment of refractory cases, is phototherapy.6 UVBNB phototherapy has been shown to be effective in many dermatological pediatric diseases associated with intense itch,7,8 and UVB light has been proven to have an inhibitory effect on mast cell degranulation, likely by causing noncytotoxic damage to the membrane phospholipid metabolism.9,10 Omalizumab has been successfully used to treat severe symptoms related to mastocytosis that are recalcitrant to conventional therapies,11 including cases of CM and ISM in pediatric patients,12 while in case of aggressive SM the clinician can consider the use of imatinib (if mast cells lack the cKIT D816V mutation) or other newer tyrosinekinase inhibitors.13 We report a case of a 13yearold girl, affected by ISM, who presented with cutaneous lesions since the sixth month of life, successfully treated with UVBNB phototherapy. The patient initially received a diagnosis of MPCM, and was referred to our Dermatologic Institute due to progressive worsening of her skin lesions during adolescence. At that time, she presented with several papules and erythematous, brown macules distributed on her face, arms, and trunk, and positivity for Darier's sign. Pruritus was one of the greatest causes of discomfort for the patient. The disfiguring appearance of the skin lesions was correlated with body image concerns, deeply affecting her quality of life (Figure 1). A progressive increase in the serum tryptase values was observed (from the baseline val
{"title":"A case of pediatric indolent systemic mastocytosis: The role of UVB-NB phototherapy in the treatment of cutaneous lesions.","authors":"Valeria Brazzelli,&nbsp;Grazia Bossi,&nbsp;Alice Bonelli,&nbsp;Eugenio Isoletta,&nbsp;Martina Volontè,&nbsp;Stefania Barruscotti,&nbsp;Mara De Amici,&nbsp;Elisa Bono,&nbsp;Jacqueline Ferrari,&nbsp;Emanuela Boveri","doi":"10.1111/phpp.12894","DOIUrl":"10.1111/phpp.12894","url":null,"abstract":"Dear editor, Mastocytosis encompasses a heterogeneous group of disorders characterized by pathological expansion and accumulation of clonal mast cells within one or more organs.1 According to the latest classification, three subtypes of the disease have been recognized based on the site and extent of organ involvement and dysfunction: cutaneous mastocytosis (CM), systemic mastocytosis (SM), and mast cell sarcoma (MCS).2,3 SM has been differentiated into nonadvanced and advanced forms, while the CM is divided into maculopapular CM (MPCM), diffuse CM (DCM), and mastocytoma subtypes.2,3 In pediatric age, mastocytosis is often limited to the skin (CM) and is considered to be a myeloproliferative clonal disease with benign course, outcome, and tendency to spontaneous resolution before puberty.4 Extracutaneous involvement in pediatric mastocytosis is relatively rare, most often presenting in the form of indolent systemic mastocytosis (ISM). Virtually all children with SM present with skin lesions, usually MPCM, accompanied by increased serum tryptase levels.4 Currently, the treatment of SM in pediatric patients lacks of standard guidelines: its primary aim is to limit the release of mediators of mast cell degranulation, by avoiding potential triggering factors. The mainstay of systemic therapy is secondgeneration H1 and H2 antihistamines, useful in decreasing flushing, pruritus, and controlling wheal formation.1,5 A valuable secondline therapy, proposed as an alternative approach for the treatment of refractory cases, is phototherapy.6 UVBNB phototherapy has been shown to be effective in many dermatological pediatric diseases associated with intense itch,7,8 and UVB light has been proven to have an inhibitory effect on mast cell degranulation, likely by causing noncytotoxic damage to the membrane phospholipid metabolism.9,10 Omalizumab has been successfully used to treat severe symptoms related to mastocytosis that are recalcitrant to conventional therapies,11 including cases of CM and ISM in pediatric patients,12 while in case of aggressive SM the clinician can consider the use of imatinib (if mast cells lack the cKIT D816V mutation) or other newer tyrosinekinase inhibitors.13 We report a case of a 13yearold girl, affected by ISM, who presented with cutaneous lesions since the sixth month of life, successfully treated with UVBNB phototherapy. The patient initially received a diagnosis of MPCM, and was referred to our Dermatologic Institute due to progressive worsening of her skin lesions during adolescence. At that time, she presented with several papules and erythematous, brown macules distributed on her face, arms, and trunk, and positivity for Darier's sign. Pruritus was one of the greatest causes of discomfort for the patient. The disfiguring appearance of the skin lesions was correlated with body image concerns, deeply affecting her quality of life (Figure 1). A progressive increase in the serum tryptase values was observed (from the baseline val","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10272275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Micro-relief characterization of benign and malignant skin lesions by polarization speckle analysis in vivo. 体内偏振斑分析良性和恶性皮肤病变的微浮雕特征。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1111/phpp.12876
Lioudmila Tchvialeva, Jamie Phillips, Daniel C Louie, Haishan Zeng, Harvey Lui, Tim K Lee

Background/purpose: A recent direction in skin disease classification is to develop quantitative diagnostic techniques. Skin relief, colloquially known as roughness, is an important clinical feature. The aim of this study is to demonstrate a novel polarization speckle technique to quantitatively measure roughness on skin lesions in vivo. We then calculate the average roughness of different types of skin lesions to determine the extent to which polarization speckle roughness measurements can be used to identify skin cancer.

Methods: The experimental conditions were set to target the fine relief structure on the order of ten microns within a small field of view of 3 mm. The device was tested in a clinical study on patients with malignant and benign skin lesions that resemble cancer. The cancer group includes 37 malignant melanomas (MM), 43 basal cell carcinomas (BCC), and 26 squamous cell carcinomas (SCC), all categories confirmed by gold standard biopsy. The benign group includes 109 seborrheic keratoses (SK), 79 nevi, and 11 actinic keratoses (AK). Normal skin roughness was obtained for the same patients (301 different body sites proximal to the lesion).

Results: The average root mean squared (rms) roughness ± standard error of the mean for MM and nevus was equal to 19 ± 5 μm and 21 ± 3 μm, respectively. Normal skin has rms roughness of 31 ± 3 μm, other lesions have roughness of 35 ± 10 μm (AK), 35 ± 7 μm (SCC), 31 ± 4 μm (SK), and 30 ± 5 μm (BCC).

Conclusion: An independent-samples Kruskal-Wallis test indicates that MM and nevus can be separated from each of the tested types of lesions, except each other. These results quantify clinical knowledge of lesion roughness and could be useful for optical cancer detection.

背景/目的:发展定量诊断技术是皮肤病分类研究的最新方向。皮肤松弛,俗称粗糙,是一个重要的临床特征。本研究的目的是展示一种新的偏振散斑技术来定量测量体内皮肤病变的粗糙度。然后,我们计算不同类型皮肤病变的平均粗糙度,以确定偏振斑粗糙度测量可以用于识别皮肤癌的程度。方法:设置实验条件,在3 mm的小视场内瞄准10微米量级的精细浮雕结构。该设备已在一项临床研究中对患有类似癌症的恶性和良性皮肤病变的患者进行了测试。癌症组包括37例恶性黑色素瘤(MM), 43例基底细胞癌(BCC)和26例鳞状细胞癌(SCC),所有类型均经金标准活检证实。良性组包括109例脂溢性角化病(SK), 79例nevi, 11例光化性角化病(AK)。相同的患者(301个不同的身体部位接近病变)获得了正常的皮肤粗糙度。结果:MM和痣的平均粗糙度均方根±标准误差分别为19±5 μm和21±3 μm。正常皮肤的rms粗糙度为31±3 μm,其他病变的粗糙度为35±10 μm (AK), 35±7 μm (SCC), 31±4 μm (SK)和30±5 μm (BCC)。结论:独立样本Kruskal-Wallis检验表明MM和痣可以从每一种被测病变类型中分离出来,但彼此除外。这些结果量化了病变粗糙度的临床知识,并可用于光学癌症检测。
{"title":"Micro-relief characterization of benign and malignant skin lesions by polarization speckle analysis in vivo.","authors":"Lioudmila Tchvialeva,&nbsp;Jamie Phillips,&nbsp;Daniel C Louie,&nbsp;Haishan Zeng,&nbsp;Harvey Lui,&nbsp;Tim K Lee","doi":"10.1111/phpp.12876","DOIUrl":"https://doi.org/10.1111/phpp.12876","url":null,"abstract":"<p><strong>Background/purpose: </strong>A recent direction in skin disease classification is to develop quantitative diagnostic techniques. Skin relief, colloquially known as roughness, is an important clinical feature. The aim of this study is to demonstrate a novel polarization speckle technique to quantitatively measure roughness on skin lesions in vivo. We then calculate the average roughness of different types of skin lesions to determine the extent to which polarization speckle roughness measurements can be used to identify skin cancer.</p><p><strong>Methods: </strong>The experimental conditions were set to target the fine relief structure on the order of ten microns within a small field of view of 3 mm. The device was tested in a clinical study on patients with malignant and benign skin lesions that resemble cancer. The cancer group includes 37 malignant melanomas (MM), 43 basal cell carcinomas (BCC), and 26 squamous cell carcinomas (SCC), all categories confirmed by gold standard biopsy. The benign group includes 109 seborrheic keratoses (SK), 79 nevi, and 11 actinic keratoses (AK). Normal skin roughness was obtained for the same patients (301 different body sites proximal to the lesion).</p><p><strong>Results: </strong>The average root mean squared (rms) roughness ± standard error of the mean for MM and nevus was equal to 19 ± 5 μm and 21 ± 3 μm, respectively. Normal skin has rms roughness of 31 ± 3 μm, other lesions have roughness of 35 ± 10 μm (AK), 35 ± 7 μm (SCC), 31 ± 4 μm (SK), and 30 ± 5 μm (BCC).</p><p><strong>Conclusion: </strong>An independent-samples Kruskal-Wallis test indicates that MM and nevus can be separated from each of the tested types of lesions, except each other. These results quantify clinical knowledge of lesion roughness and could be useful for optical cancer detection.</p>","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10331110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective multicentric cohort study of checkpoint inhibitors-induced pruritus with focus on management. 检查点抑制剂诱发瘙痒的多中心回顾性队列研究,重点是治疗。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1111/phpp.12892
Chryssoula Papageorgiou, Elizabeth Lazaridou, Konstantinos Lallas, Kyparissos Papaioannou, Vasiliki Nikolaou, Valeria Mateeva, Konstantinos Efthymiadis, Chrysanthi Koukoutzeli, Konstantia Loga, Eleni Sogka, Evangelos Karamitrousis, George Lazaridis, Dimitrios Dionysopoulos, Aimilios Lallas, Christina Kemanetzi, Christina Fotiadou, Eleni Timotheadou, Zoe Apalla

Background: Limited data on immune checkpoint inhibitor (ICI)-induced pruritus per se and efficacy of different therapeutic modalities in its management exist.

Objective: To study the quantitative and qualitative characteristics of ICI-induced pruritus per se and to assess the efficacy of the therapeutic modalities usually applied.

Methods: We retrospectively reviewed the records of 91 patients who were under treatment with ICIs for any kind of neoplasia and developed pruritus during treatment.

Results: Twenty out of 91 individuals (22.0%) with ICI-induced pruritus had pruritus as the only symptom, while 71/91 (78.0%) presented with pruritus coexisting with an additional cutaneous toxicity. Pruritus was treated with antihistamines (18/20, 90.0%) and/or topical regimens, as first-line choice. In resistant cases, as a second therapeutic intervention, narrow-band UVB (NBUVB), oral steroids and GABA analogs were added (70.0%). Statistical analysis revealed a significant difference in mean pruritus Numerical Rating Scale (NRS) scores between baseline and sequential visits. Moreover, subgroup analysis revealed a significant reduction in mean NRS scores in those treated with phototherapy.

Limitations: Retrospective design, low number of patients and survivorship bias.

Conclusion: Pruritus per se was present in a substantial portion of our cohort (22.0%). Our study confirms the efficacy of current treatment strategies and suggests NBUVB as a potential steroid-sparing therapeutic alternative.

背景:关于免疫检查点抑制剂(ICI)引起的瘙痒本身和不同治疗方式在其管理中的疗效的数据有限。目的:研究ici致瘙痒本身的定量和定性特征,评价常用治疗方法的疗效。方法:回顾性分析91例因不同类型肿瘤而使用ICIs治疗并在治疗过程中出现瘙痒的患者。结果:91例ci致瘙痒患者中有20例(22.0%)以瘙痒为唯一症状,71例(78.0%)伴有皮肤毒性。瘙痒用抗组胺药(18/ 20,90.0%)和/或局部治疗方案作为一线选择。在耐药病例中,作为第二次治疗干预,添加窄带UVB (NBUVB)、口服类固醇和GABA类似物(70.0%)。统计分析显示,基线和连续就诊的平均瘙痒数值评定量表(NRS)评分有显著差异。此外,亚组分析显示,接受光疗治疗的患者平均NRS评分显著降低。局限性:回顾性设计,患者数量少,生存偏倚。结论:瘙痒本身存在于我们的队列中很大一部分(22.0%)。我们的研究证实了当前治疗策略的有效性,并建议NBUVB作为一种潜在的类固醇节省治疗替代方案。
{"title":"A retrospective multicentric cohort study of checkpoint inhibitors-induced pruritus with focus on management.","authors":"Chryssoula Papageorgiou,&nbsp;Elizabeth Lazaridou,&nbsp;Konstantinos Lallas,&nbsp;Kyparissos Papaioannou,&nbsp;Vasiliki Nikolaou,&nbsp;Valeria Mateeva,&nbsp;Konstantinos Efthymiadis,&nbsp;Chrysanthi Koukoutzeli,&nbsp;Konstantia Loga,&nbsp;Eleni Sogka,&nbsp;Evangelos Karamitrousis,&nbsp;George Lazaridis,&nbsp;Dimitrios Dionysopoulos,&nbsp;Aimilios Lallas,&nbsp;Christina Kemanetzi,&nbsp;Christina Fotiadou,&nbsp;Eleni Timotheadou,&nbsp;Zoe Apalla","doi":"10.1111/phpp.12892","DOIUrl":"https://doi.org/10.1111/phpp.12892","url":null,"abstract":"<p><strong>Background: </strong>Limited data on immune checkpoint inhibitor (ICI)-induced pruritus per se and efficacy of different therapeutic modalities in its management exist.</p><p><strong>Objective: </strong>To study the quantitative and qualitative characteristics of ICI-induced pruritus per se and to assess the efficacy of the therapeutic modalities usually applied.</p><p><strong>Methods: </strong>We retrospectively reviewed the records of 91 patients who were under treatment with ICIs for any kind of neoplasia and developed pruritus during treatment.</p><p><strong>Results: </strong>Twenty out of 91 individuals (22.0%) with ICI-induced pruritus had pruritus as the only symptom, while 71/91 (78.0%) presented with pruritus coexisting with an additional cutaneous toxicity. Pruritus was treated with antihistamines (18/20, 90.0%) and/or topical regimens, as first-line choice. In resistant cases, as a second therapeutic intervention, narrow-band UVB (NBUVB), oral steroids and GABA analogs were added (70.0%). Statistical analysis revealed a significant difference in mean pruritus Numerical Rating Scale (NRS) scores between baseline and sequential visits. Moreover, subgroup analysis revealed a significant reduction in mean NRS scores in those treated with phototherapy.</p><p><strong>Limitations: </strong>Retrospective design, low number of patients and survivorship bias.</p><p><strong>Conclusion: </strong>Pruritus per se was present in a substantial portion of our cohort (22.0%). Our study confirms the efficacy of current treatment strategies and suggests NBUVB as a potential steroid-sparing therapeutic alternative.</p>","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10627469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer. 一项多中心病例对照研究比较了不同类型皮肤癌患者的阳光照射习惯和光防护措施的使用情况。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-09-01 DOI: 10.1111/phpp.12878
Alba Navarro-Bielsa, Tamara Gracia-Cazaña, Manuel Almagro, Sonia De la Fuente-Meira, Ángeles Florez, Oriol Yélamos, Trinidad Montero-Vilchez, Carlos González-Cruz, Adrián Diago, Isabel Abadías-Granado, Victoria Fuentelsaz, María Colmenero, José Bañuls, Salvador Arias-Santiago, Agustín Buendía-Eisman, Manuel Almenara-Blasco, Pedro Gil-Pallares, Yolanda Gilaberte

Background: While skin cancer awareness programs have significantly furthered public understanding about the harmful effects of the sun, there is a disparity between photoprotection knowledge and protection practices.

Objective: To compare sun exposure habits and photoprotection measures in patients diagnosed with basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma versus controls.

Methods: Multicentre case-control observational study carried out by 13 Spanish dermatologists between April 2020 and August 2022. Patients diagnosed with BCC, SCC, or melanoma were considered cases. The control group consisted of individuals with no history of skin cancer.

Results: Of the 254 cases (56.2% female; mean age, 62.67 ± 15.65), 119 (31.2%) had BCC, 62 (16.27%) SCC, and 73 (19.1%) melanoma. The control group consisted of 127 (33.33%) individuals. Avoiding sun exposure between 12:00 and 16:00 was the most commonly used photoprotection measure (habitually/always: 63.1%), followed by the use of sunscreen (habitually/always: 58.9%). Patients with melanoma were less likely to use clothing and shade to avoid sun exposure (p < .05), whereas those with BCC and SCC reported greater use of head coverings (p = .01). BCC and SCC groups reported greater sun exposure 15 years prior, whereas controls reported greater use of sunscreen. However, at the time of this study all groups reported using SPF ≥ 21, and the majority SPF > 50. No differences were observed in photoprotection measures between people with and without a previous history of skin cancer.

Conclusions: We describe differences in photoprotection measures and sun exposure patterns among patients diagnosed with different skin tumor types. Whether these differences may influence the type of tumor each developed will require further investigation.

背景:虽然皮肤癌意识项目大大提高了公众对太阳有害影响的认识,但光防护知识和防护实践之间存在差距。目的:比较基底细胞癌(BCC)、鳞状细胞癌(SCC)和黑色素瘤患者与对照组的阳光照射习惯和光防护措施。方法:由13名西班牙皮肤科医生于2020年4月至2022年8月进行的多中心病例对照观察性研究。诊断为BCC, SCC或黑色素瘤的患者被认为是病例。对照组由没有皮肤癌病史的个体组成。结果:254例患者中,女性占56.2%;平均年龄62.67±15.65),BCC 119 (31.2%), SCC 62(16.27%),黑色素瘤73(19.1%)。对照组127例(33.33%)。在12:00至16:00期间避免日晒是最常用的光防护措施(习惯性/总是:63.1%),其次是使用防晒霜(习惯性/总是:58.9%)。黑色素瘤患者不太可能使用衣服和遮阳处来避免阳光照射。在有和没有皮肤癌病史的人群中,没有观察到光防护措施的差异。结论:我们描述了诊断为不同皮肤肿瘤类型的患者在光防护措施和阳光照射模式上的差异。这些差异是否会影响肿瘤的类型还需要进一步的研究。
{"title":"A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer.","authors":"Alba Navarro-Bielsa,&nbsp;Tamara Gracia-Cazaña,&nbsp;Manuel Almagro,&nbsp;Sonia De la Fuente-Meira,&nbsp;Ángeles Florez,&nbsp;Oriol Yélamos,&nbsp;Trinidad Montero-Vilchez,&nbsp;Carlos González-Cruz,&nbsp;Adrián Diago,&nbsp;Isabel Abadías-Granado,&nbsp;Victoria Fuentelsaz,&nbsp;María Colmenero,&nbsp;José Bañuls,&nbsp;Salvador Arias-Santiago,&nbsp;Agustín Buendía-Eisman,&nbsp;Manuel Almenara-Blasco,&nbsp;Pedro Gil-Pallares,&nbsp;Yolanda Gilaberte","doi":"10.1111/phpp.12878","DOIUrl":"https://doi.org/10.1111/phpp.12878","url":null,"abstract":"<p><strong>Background: </strong>While skin cancer awareness programs have significantly furthered public understanding about the harmful effects of the sun, there is a disparity between photoprotection knowledge and protection practices.</p><p><strong>Objective: </strong>To compare sun exposure habits and photoprotection measures in patients diagnosed with basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma versus controls.</p><p><strong>Methods: </strong>Multicentre case-control observational study carried out by 13 Spanish dermatologists between April 2020 and August 2022. Patients diagnosed with BCC, SCC, or melanoma were considered cases. The control group consisted of individuals with no history of skin cancer.</p><p><strong>Results: </strong>Of the 254 cases (56.2% female; mean age, 62.67 ± 15.65), 119 (31.2%) had BCC, 62 (16.27%) SCC, and 73 (19.1%) melanoma. The control group consisted of 127 (33.33%) individuals. Avoiding sun exposure between 12:00 and 16:00 was the most commonly used photoprotection measure (habitually/always: 63.1%), followed by the use of sunscreen (habitually/always: 58.9%). Patients with melanoma were less likely to use clothing and shade to avoid sun exposure (p < .05), whereas those with BCC and SCC reported greater use of head coverings (p = .01). BCC and SCC groups reported greater sun exposure 15 years prior, whereas controls reported greater use of sunscreen. However, at the time of this study all groups reported using SPF ≥ 21, and the majority SPF > 50. No differences were observed in photoprotection measures between people with and without a previous history of skin cancer.</p><p><strong>Conclusions: </strong>We describe differences in photoprotection measures and sun exposure patterns among patients diagnosed with different skin tumor types. Whether these differences may influence the type of tumor each developed will require further investigation.</p>","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10626900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular protection in congenital erythropoietic porphyria: A potential role for gaming glasses. 先天性红细胞生成性卟啉的眼部保护:游戏眼镜的潜在作用。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2023-09-01 Epub Date: 2023-06-12 DOI: 10.1111/phpp.12889
A Fityan, G A Aneju, A M S Morley, R Sarkany
Congenital erythropoietic porphyria (CEP) or Günthers disease is a rare hematological porphyria, which occurs due to an inherited reduction in activity of the uroporphyrinogen III synthase enzyme (UROS). This results in the accumulation of water soluble, type I isomer porphyrins in the skin.1 Exposure to violet light in the Soret waveband (roughly 400– 410 nm) leads to the development of blisters on exposed skin, scar formation and subsequent disfigurement. Uroporphyrins are also deposited in other body tissues including the eye. Exposure of the ocular surface to violet light leads to vesicle formation, scarring, and symblephara. Scleral damage includes both acute scleritis and slowly progressive scleral necrosis, and may be accompanied by corneal thinning, perforation, visual loss and significant morbidity.2,3 Early education regarding the importance of photoprotection for patients with CEP is vital to limit the development of irreversible ocular damage. Many sunglasses offer a high level of protection against UVA and UVB helping to prevent against chronic UV exposurerelated cataract and pterygium formation. However, the protection afforded by standard sunglasses is only guaranteed up to 380 nm in Europe (BS EN ISO 123121:2013) and thus offers patients with CEP little or no protection against ocular damage caused by porphyrinrelated, short wavelength, visible light.4 Despite this, patients with CEP rely on standard sunglasses or, in some instances, nothing at all, given that the orangetinted lenses that provide protection against short wavelength visible light are often considered cosmetically unacceptable. Such behavior puts patients at risk of exposure to potentially damaging levels of visible light. In recent years, there has been increasing public awareness of the negative impact of exposure to artificial blue light on sleep.5,6 This has led to the manufacture and marketing of blue light protecting glasses to protect the eyes against blue light from computer and mobile device screens (gaming glasses). In view of these potentially useful properties for patients with porphyria, we undertook a small study to assess the wavelength of light blocked by these lenses to determine whether the protection might be sufficient to recommend their use in CEP. Seven different pairs of gaming spectacles were randomly selected and purchased online via Amazon UK marketplace (Table 1). The optical transmission characteristics of all lenses were measured using a DMC150 Bentham spectroradiometer (Bentham Instruments) in a radiation beam from an Abet 2000 Solar Simulator (Abet Technologies, Inc) in the ultraviolet and near visible region from 250 to 500 nm. Comparison of the transmitted spectrum of each lens with that of the unfiltered monochromator was used to derive the lens transmission.7 Of the seven spectacles (G1– G7) tested, five reduced transmission within the CEP spectral band (400– 415 nm) by more than 94% and six by more than 87%. Two pairs of glasses,
{"title":"Ocular protection in congenital erythropoietic porphyria: A potential role for gaming glasses.","authors":"A Fityan,&nbsp;G A Aneju,&nbsp;A M S Morley,&nbsp;R Sarkany","doi":"10.1111/phpp.12889","DOIUrl":"10.1111/phpp.12889","url":null,"abstract":"Congenital erythropoietic porphyria (CEP) or Günthers disease is a rare hematological porphyria, which occurs due to an inherited reduction in activity of the uroporphyrinogen III synthase enzyme (UROS). This results in the accumulation of water soluble, type I isomer porphyrins in the skin.1 Exposure to violet light in the Soret waveband (roughly 400– 410 nm) leads to the development of blisters on exposed skin, scar formation and subsequent disfigurement. Uroporphyrins are also deposited in other body tissues including the eye. Exposure of the ocular surface to violet light leads to vesicle formation, scarring, and symblephara. Scleral damage includes both acute scleritis and slowly progressive scleral necrosis, and may be accompanied by corneal thinning, perforation, visual loss and significant morbidity.2,3 Early education regarding the importance of photoprotection for patients with CEP is vital to limit the development of irreversible ocular damage. Many sunglasses offer a high level of protection against UVA and UVB helping to prevent against chronic UV exposurerelated cataract and pterygium formation. However, the protection afforded by standard sunglasses is only guaranteed up to 380 nm in Europe (BS EN ISO 123121:2013) and thus offers patients with CEP little or no protection against ocular damage caused by porphyrinrelated, short wavelength, visible light.4 Despite this, patients with CEP rely on standard sunglasses or, in some instances, nothing at all, given that the orangetinted lenses that provide protection against short wavelength visible light are often considered cosmetically unacceptable. Such behavior puts patients at risk of exposure to potentially damaging levels of visible light. In recent years, there has been increasing public awareness of the negative impact of exposure to artificial blue light on sleep.5,6 This has led to the manufacture and marketing of blue light protecting glasses to protect the eyes against blue light from computer and mobile device screens (gaming glasses). In view of these potentially useful properties for patients with porphyria, we undertook a small study to assess the wavelength of light blocked by these lenses to determine whether the protection might be sufficient to recommend their use in CEP. Seven different pairs of gaming spectacles were randomly selected and purchased online via Amazon UK marketplace (Table 1). The optical transmission characteristics of all lenses were measured using a DMC150 Bentham spectroradiometer (Bentham Instruments) in a radiation beam from an Abet 2000 Solar Simulator (Abet Technologies, Inc) in the ultraviolet and near visible region from 250 to 500 nm. Comparison of the transmitted spectrum of each lens with that of the unfiltered monochromator was used to derive the lens transmission.7 Of the seven spectacles (G1– G7) tested, five reduced transmission within the CEP spectral band (400– 415 nm) by more than 94% and six by more than 87%. Two pairs of glasses, ","PeriodicalId":20123,"journal":{"name":"Photodermatology, photoimmunology & photomedicine","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10332135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Photodermatology, photoimmunology & photomedicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1